Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02JMI
|
||||
| Former ID |
DCL000988
|
||||
| Drug Name |
SLV-310
|
||||
| Synonyms |
L001635; 2-[4-[4-(5-fluoro-1H-indol-3-yl)-3,6-dihydro-2H-pyridin-1-yl]butyl]isoindole-1,3-dione
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Schizophrenia [ICD9: 295; ICD10:F20] | Discontinued in Phase 2 | [536463] | ||
| Company |
Solvay Pharma
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C25H24FN3O2
|
||||
| Canonical SMILES |
C1CN(CC=C1C2=CNC3=C2C=C(C=C3)F)CCCCN4C(=O)C5=CC=CC=C5C4<br />=O
|
||||
| InChI |
1S/C25H24FN3O2/c26-18-7-8-23-21(15-18)22(16-27-23)17-9-13-28(14-10-17)11-3-4-12-29-24(30)19-5-1-2-6-20(19)25(29)31/h1-2,5-9,15-16,27H,3-4,10-14H2
|
||||
| InChIKey |
NECJNLXOJRDELU-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | D(2) dopamine receptor | Target Info | Modulator | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.